AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,462,000 | -99.8% | 860,000 | 0.0% | 4.73% | +89.3% |
| Q3 2019 | $24,157,400,000 | -33.9% | 860,000 | -10.9% | 2.50% | -26.9% |
| Q2 2019 | $36,534,900,000 | +92604.6% | 965,000 | -4.5% | 3.42% | -21.0% |
| Q1 2019 | $39,410,000 | +114.9% | 1,010,000 | +17.4% | 4.33% | +38.0% |
| Q4 2018 | $18,335,000 | -25.9% | 860,000 | +37.6% | 3.14% | +4.3% |
| Q3 2018 | $24,744,000 | +43.9% | 625,000 | +38.9% | 3.01% | +25.0% |
| Q2 2018 | $17,195,000 | +27.2% | 450,000 | 0.0% | 2.40% | +1.1% |
| Q1 2018 | $13,523,000 | +8.2% | 450,000 | +12.5% | 2.38% | -21.9% |
| Q4 2017 | $12,500,000 | +11.6% | 400,000 | 0.0% | 3.04% | -3.8% |
| Q3 2017 | $11,204,000 | +46.4% | 400,000 | 0.0% | 3.16% | +11.8% |
| Q2 2017 | $7,652,000 | +72.7% | 400,000 | +53.8% | 2.83% | +8.3% |
| Q1 2017 | $4,430,000 | – | 260,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |